Spontaneous Extradural Hematoma in a Sickle Cell Anemia Patient with Hyperinflammation and Thrombotic Microangiopathy Successfully Treated with Eculizumab: A Case Report and Review of the Literature.
Michael Itak ItaPia OlesenMaria RosingMorten MørkHalldór Bjarki EinarssonJens Jakob RiisPublished in: Journal of neurological surgery. Part A, Central European neurosurgery (2024)
Treatment with the anti-C5 monoclonal antibody eculizumab, which targets and inhibits terminal complement system activation, reversed the deleterious cascade of events in this patient with sickle cell disease.
Keyphrases